Delivery Order SPE2DB22D9353-SPE2DB24FX1PN
Award Date 12/13/23
Potential Completion Date 12/14/23
Potential Value $56K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-seven thousand fifty-three dollars and sixty-eight cents ($37,053.68) by the Defense Logistics Agency to provide TRIKAFTA 100-50-75 MG/75MG PKT 14S. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through December...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one hundred two thousand five hundred ninety-seven dollars and four cents ($102,597.04) by the Defense Logistics Agency to supply TRIKAFTA 100-50-75 MG/150 MG UU 84S. The order is being issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars ($5,000,000)...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-six thousand, six hundred thirty-seven dollars and fifty-two cents ($36,637.52) by the Defense Logistics Agency to provide TRIKAFTA 100-50-75 MG/150 MG UU 84S. The delivery order was awarded on November 14, 2023 and is to be completed by November 15, 2023. DMS Pharmaceutical Group Inc. will fulfill this order as a prime contractor under an existing indefinite delivery contract with the Defense...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty-four thousand nine hundred fifty-six dollars and twenty-five cents ($54,956.25) by the Defense Logistics Agency to supply TRIKAFTA 100-50-75 MG/150 MG UU 84S. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one hundred eighty-three thousand one hundred eighty-seven dollars and sixty cents ($183,187.60) by the Defense Logistics Agency to supply TRIKAFTA 100-50-75 MG/150 MG UU 84S. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-six thousand six hundred forty-seven dollars and four cents ($36,647.04) by the Defense Logistics Agency to provide TRIKAFTA 50-25-37.5 MG/75 MG UU 84S. The delivery order was issued on September 22, 2023 with a completion date of September 25, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies. The...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $18,318.75 under an indefinite delivery contract with the Defense Logistics Agency. The delivery order is for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S to fulfill requirements at a Defense Logistics Agency Troop Support Medical facility located in Park Ridge, Illinois. Performance is required by November 29, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-six thousand, six hundred thirty-seven dollars and fifty-two cents ($36,637.52) by the Defense Logistics Agency to provide TRIKAFTA 100-50-75 MG/150 MG UU 84S. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to five million...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $18,318.75 by the Defense Logistics Agency to provide TRIKAFTA 100-50-75 MG/150 MG UU 84S. The order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business, DMS Pharmaceutical Group will deliver the specified...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-six thousand six hundred fifty-six dollars and sixty cents ($36,656.60) by the Defense Logistics Agency to supply TRIKAFTA 50-25-37.5 MG/75 MG UU 84S. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025....
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB24FX1PNDelivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty-five thousand five hundred eighty dollars and forty-nine cents ($55,580.49) by the Defense Logistics Agency to provide TRIKAFTA 100-50-75 MG/75MG PKT 14S. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products with a potential value of up to five million dollars through December 2025. No set-aside designation was used for this award. Performance will take place in Park Ridge, Illinois and is scheduled for completion by December 14, 2023.
Generated 3/13/24, 10:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.6k | 12/13/23 |